Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mirati Therapeutics
(NQ:
MRTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mirati Therapeutics
< Previous
1
2
3
4
5
6
7
8
Next >
MRTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Mirati Therapeutics, Inc. Is Fair to Shareholders
October 08, 2023
From
Halper Sadeh LLC
Via
Business Wire
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
October 08, 2023
From
Bristol Myers Squibb
Via
Business Wire
Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts
October 06, 2023
According to a report on Thursday, French pharma company Sanofi SA (NASDAQ: SNY) is reportedly exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc (NASDAQ: MRTX).
Via
Benzinga
What's Going On With Mirati Therapeutics Stock?
October 06, 2023
Mirati Therapeutics, Inc. (NASDAQ: MRTX) shares are trading higher Friday.
Via
Benzinga
Why Shares of Mirati Therapeutics Are Jumping Wednesday
August 09, 2023
The company replaced its CEO and reported strong revenue growth.
Via
The Motley Fool
8 Analysts Have This to Say About Mirati Therapeutics
July 14, 2023
Via
Benzinga
Expert Ratings for Mirati Therapeutics
June 16, 2023
Via
Benzinga
FDA Adcomm Gives Thumbs Down To Amgen's Lumakras For Advanced Form Of Lung Cancer
October 06, 2023
FDA advisers concluded that the data from a late-stage trial lacked the requisite reliability to endorse the traditional approval of Amgen Inc's (NASDAQ: AMGN) Lumakras for patients afflicted with an...
Via
Benzinga
Exposures
Product Safety
Pancreatic Cancer Battle Boosted by $200M VC Firm
September 19, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:MACK),(NASDAQ:INCY),(NASDAQ:MRTX),(NASDAQ:BNTX) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
3 Under-the-Radar Biotech Stocks to Buy in 2023
August 19, 2023
All three biotech companies focus on oncology therapies.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
August 10, 2023
Via
Benzinga
Mirati Therapeutics, Inc. (NASDAQ:MRTX) Investor Alert: Investigation over Possible Breaches of Fiduciary Duties
May 11, 2023
San Diego, CA -- (SBWIRE) -- 05/11/2023 -- Certain directors of Mirati Therapeutics, Inc are under investigation over potential breaches of fiduciary duties.
Via
SBWire
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
August 09, 2023
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.
Via
Benzinga
Analyst Expectations for Mirati Therapeutics's Future
May 11, 2023
Via
Benzinga
Mirati Therapeutics: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
August 09, 2023
U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
August 09, 2023
Via
Benzinga
Mirati Rockets 26% On A Bevy Of News In Cancer, A $300 Million Deal And Its CEO Exit
August 09, 2023
The company announced updates in cancer, a quarterly beat, a $300 million deal and its CEO departure.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 08, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 21, 2023
On Friday, 54 companies hit new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
July 27, 2023
Via
Benzinga
Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 21, 2023
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 21, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 18, 2023
During Tuesday's trading, 46 companies set new 52-week lows.
Via
Benzinga
Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2
June 02, 2023
Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics.
Via
Talk Markets
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs
June 22, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:POAI),(NASDAQ:AGLE),(NASDAQ:TALS),(NASDAQ:MRTX) EQNX::TICKER_END
Via
FinancialNewsMedia
Mirati's Sitravatinib Flunks Phase 3 Combo Therapy Study In Type Of Lung Cancer Setting
May 25, 2023
Via
Benzinga
Snowflake, American Eagle, Digital Turbine And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
May 25, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Why Dollar Tree Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 25, 2023
Gainers Beamr Imaging Ltd. (NASDAQ: BMR) shares climbed 211.6% to $6.86 after NVIDIA announced the release of NVENC Video Codec SDK 12.1 showcasing the integration with Beamr CABR.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.